Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels - PubMed (original) (raw)
Clinical Trial
Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels
L Bjerkenstedt et al. Eur J Clin Pharmacol. 1985.
Abstract
Three dose levels (5, 25, and 50 mg once daily) of the selective serotonin uptake inhibitor citalopram were compared in a four-week, double-blind trial in depressed patients. Serum levels of citalopram and desmethylcitalopram, and the inhibitory effect of serum on serotonin uptake by fresh platelets, were assessed once weekly during the trial. The serum concentrations of citalopram were highly correlated with inhibition of serotonin uptake. Less of the metabolite was found, it being detected only in the higher dose groups. Steady state levels of citalopram, attained after 1 week, were linearly related to dose. The relationship between improvement (percentage reduction in total score on the Montgomery-Asberg Depression Rating Scale) and serum level of citalopram indicated a lower limit of effect in endogenous depression at about 100 nM, corresponding to an average dose of 15 mg. Marked improvement was seen in ten patients with steady state levels in the range 70 to 335 nM. The ten nonendogenously depressed patients had steady state levels from 15 to 620 nM; complete remission was seen in the three with the lowest levels (15-25 nM). No significant correlation was found between serum drug level and the few reported side effects.
Similar articles
- Initial, clinical trial of a new, specific 5-HT reuptake inhibitor, citalopram (Lu 10-171).
Gottlieb P, Wandall T, Overø KF. Gottlieb P, et al. Acta Psychiatr Scand. 1980 Sep;62(3):236-44. doi: 10.1111/j.1600-0447.1980.tb00611.x. Acta Psychiatr Scand. 1980. PMID: 6935914 - A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients.
Timmerman L, de Beurs P, Tan BK, Leijnse-Ybema H, Sanchez C, Høpfner Petersen HE, Cohen Stuart MH. Timmerman L, et al. Int Clin Psychopharmacol. 1987 Jul;2(3):239-53. doi: 10.1097/00004850-198707000-00006. Int Clin Psychopharmacol. 1987. PMID: 2447151 Clinical Trial. - Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long-term effect--a phase II study.
Pedersen OL, Kragh-Sørensen P, Bjerre M, Overø KF, Gram LF. Pedersen OL, et al. Psychopharmacology (Berl). 1982;77(3):199-204. doi: 10.1007/BF00464566. Psychopharmacology (Berl). 1982. PMID: 6812140 - Therapeutic effects of serotonin uptake inhibitors in depression.
Asberg M, Eriksson B, Mårtensson B, Träskman-Bendz L, Wägner A. Asberg M, et al. J Clin Psychiatry. 1986 Apr;47 Suppl:23-35. J Clin Psychiatry. 1986. PMID: 2937776 Review. - Clinical experience with serotonin reuptake inhibiting antidepressants.
Mendels J. Mendels J. J Clin Psychiatry. 1987 Mar;48 Suppl:26-30. J Clin Psychiatry. 1987. PMID: 2950077 Review.
Cited by
- Toward therapeutic drug monitoring of citalopram in depression? Insights from a systematic review.
Xu N, Song Z, Jiang D, Zhao R. Xu N, et al. Front Psychiatry. 2023 Apr 27;14:1144573. doi: 10.3389/fpsyt.2023.1144573. eCollection 2023. Front Psychiatry. 2023. PMID: 37181880 Free PMC article. - Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake.
Blom T, Meinsma R, Rutgers M, Buitenhuis C, Dekken-Van den Burg M, van Kuilenburg ABP, Tytgat GAM. Blom T, et al. EJNMMI Res. 2020 Jul 8;10(1):78. doi: 10.1186/s13550-020-00662-w. EJNMMI Res. 2020. PMID: 32642907 Free PMC article. - Serum N-Desmethylcitalopram Concentrations are Associated with the Clinical Response to Citalopram of Patients with Major Depression.
Ozbey G, Yucel B, Bodur NE, Taycan SE, Arslan T, Cerit N, Yuksel N, Guzey IC, Uluoglu C. Ozbey G, et al. Psychiatry Investig. 2018 Mar;15(3):313-319. doi: 10.30773/pi.2017.05.22. Epub 2018 Feb 22. Psychiatry Investig. 2018. PMID: 29475241 Free PMC article. - Quantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetine.
Margiotta-Casaluci L, Owen SF, Cumming RI, de Polo A, Winter MJ, Panter GH, Rand-Weaver M, Sumpter JP. Margiotta-Casaluci L, et al. PLoS One. 2014 Oct 22;9(10):e110467. doi: 10.1371/journal.pone.0110467. eCollection 2014. PLoS One. 2014. PMID: 25338069 Free PMC article. - Lasting neurobehavioral abnormalities in rats after neonatal activation of serotonin 1A and 1B receptors: possible mechanisms for serotonin dysfunction in autistic spectrum disorders.
Khatri N, Simpson KL, Lin RC, Paul IA. Khatri N, et al. Psychopharmacology (Berl). 2014 Mar;231(6):1191-200. doi: 10.1007/s00213-013-3242-2. Epub 2013 Aug 24. Psychopharmacology (Berl). 2014. PMID: 23975037 Free PMC article.
References
- Acta Psychiatr Scand. 1985 Jul;72(1):89-96 - PubMed
- J Clin Psychopharmacol. 1984 Apr;4(2):76-81 - PubMed
- Br Med J. 1970 Oct 3;4(5726):18-21 - PubMed
- Prog Neuropsychopharmacol Biol Psychiatry. 1982;6(3):311-8 - PubMed
- Psychopharmacology (Berl). 1984;82(4):275-81 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources